Effects of dapagliflozin on the development and progression of renal failure in patients with type 2 diabetes: randomized trial analysis DECLARE – TIMI 58 – The Lancet

[ad_1]

1. Effects of dapagliflozin on the development and progression of renal failure in patients with type 2 diabetes: randomized trial badysis DECLARE – TIMI 58, The Lancet
2. Results for dulaglutide and kidney in type 2 diabetes: exploratory badysis of the randomized, placebo-controlled trial of REWIND, The Lancet
3. Risks of Similar Cardiovascular Events in Type 1 and Type 2 Diabetes Patients MD Magazine
4. View full coverage on Google News

[ad_2]
Source link